Algernon Pharmaceuticals (TSE:AGN) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Algernon Pharmaceuticals invites stakeholders to a special CEO interview and Q&A session with CEO Christopher J. Moreau, hosted by Market Radius Research on April 16th, 2024. The discussion will cover the recent Ifendprodil deal and future plans for the company’s DMT stroke research. Attendees can interact live or access the archived webcast later.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.
